Blood Ketone Meter Market

Blood Ketone Meter Market, by Product Type (Only Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, and Consumables), by Application (Human and Veterinary), by End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Home Care Settings, Veterinary Hospitals and Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Blood ketone meters are devices that are used to measure the levels of ketones in the blood of people with diabetes, specifically 3-beta-hydroxybutyrate (beta-OHB). These meters are particularly important for people with type 1 diabetes because they are at a higher risk of developing diabetic ketoacidosis (DKA) due to low insulin levels. Ketones are produced when the body breaks down fats for energy, and excessive production can lead to ketoacidosis, which can be dangerous to the organs. Normal blood ketone values are below 0.6mmol/L, while values above 3.0mmol/L are considered dangerous and require immediate medical attention. It is recommended that people with type 1 diabetes use blood ketone meters to monitor their ketone levels when their blood sugar is over 17mmol/l or if they are unwell and experiencing symptoms of ketoacidosis. However, it is important to note that ketone testing should not be used for weight loss purposes, and the test strips provided by GP should not be used for this purpose.

Market Dynamics

The global blood ketone meter market is anticipated to develop as a result of rising diabetic ketoacidosis instances and rising diabetes incidence. In 2021, diabetes is the cause of 6.7 million fatalities, or one every five seconds. For instance, according to the International Diabetes Federation Report, 2021, around 537 million adults in the age group 20 to 79 years were suffering from diabetes worldwide in 2021, and is estimated to reach 783 million by 2045. According to the Centers for Disease Control and Prevention (CDC), in March 2021, around 60 per 1,000 patients were hospitalized due to diabetic ketoacidosis in the U.S. from 2012 to 2018.

Moreover, several launches of blood glucose monitoring devices and approvals of funding for new blood ketone meters are also expected to boost growth of the blood ketone meter market over the forecast period. For instance, in March 2021, EKF Diagnostics (Entwicklung, Konstruktion und Fertigung) globally launched its STAT-Site WB handheld analyzer, a product that delivers β-ketone and glucose measurements from whole blood in seconds. The device can be used with arterial, venous, or capillary specimens from all patients including critically ill patients.

Key features of the study:

This report provides in-depth analysis of the global blood ketone meter market (US$ MN), and compound annual growth rate (CAGR (%)) for the forecast period: 2023-2030, considering 2022 as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.

It profiles key players in the global blood ketone meter market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies.

Key players covered as a part of this study include Abbott Laboratories, ACON Laboratories Inc., Keto-Mojo, EKF Diagnostics, Taidoc Technology Corporation, Apex Biotechnology Corporation, Bruno MD, Nova Biomedical, Nipro Corporation, ForaCare Inc., GlucoRx Limited, and PortaCheck Inc.

Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global blood ketone meter market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for the blood ketone meter market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

Global Blood Ketone Meter Market, By Product Type:

Only Blood Ketone Monitoring

Blood Glucose and Ketone Monitoring

Consumables

Global Blood Ketone Meter Market, By Application:

Human

Veterinary

Global Blood Ketone Meter Market, By End User:

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

Home Care Settings

Veterinary Hospitals and Clinics

Global Blood Ketone Meter Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East:

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country:

South Africa

Central Africa

North Africa

Company Profiles

Abbott Laboratories*

Company Overview

Product Portfolio

Recent Highlights

Financial Performance

Strategies

ACON Laboratories Inc.

Keto-Mojo

EKF Diagnostics

Taidoc Technology Corporation

Apex Biotechnology Corporation

Bruno MD

Nova Biomedical

Nipro Corporation

ForaCare Inc.

GlucoRx Limited

PortaCheck Inc.

“*” marked represents similar segmentation in other categories in the respective section.